Viral hepatitis elimination challenges in low‐ and middle‐income countries—Uzbekistan Hepatitis Elimination Program (UHEP)
Erkin Musabaev(Hai phong University Of Medicine and Pharmacy), Homie Razavi(Center for Disease Analysis), Shakhlo Sadirova(Tashkent Chemical-Technological Institute), Bakhodir Yusupaliev(Ministry of Health of the Republic of Uzbekistan), Poonam Mathur(Center for Disease Analysis), Rick Dunn(Tashkent Chemical-Technological Institute), Krestina Brigida(Center for Disease Analysis), Tim Anstiss(University of Southampton), Kathryn Razavi‐Shearer(Center for Disease Analysis), Ameer Abutaleb(University of Maryland, Baltimore), Chris Estes(Center for Disease Analysis), Shyamasundaran Kottilil(University of Maryland, Baltimore), Shokhista Bakieva(Center for Disease Analysis)
Cited by 26
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Global epidemiology and genotype distribution of the hepatitis C virus infection
|Journal of Hepatology|2014|1.9k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484